The United Laboratories International Holdings Limited (3933.HK)

HKD 13.38

(0.45%)

Net Income Summary of The United Laboratories International Holdings Limited

  • The United Laboratories International Holdings Limited's latest annual net income in 2023 was 2.7 Billion CNY , up 70.85% from previous year.
  • The United Laboratories International Holdings Limited's latest quarterly net income in 2024 Q2 was 1.49 Billion CNY , down 0.0% from previous quarter.
  • The United Laboratories International Holdings Limited reported an annual net income of 1.58 Billion CNY in 2022, up 60.01% from previous year.
  • The United Laboratories International Holdings Limited reported an annual net income of 988.09 Million CNY in 2021, up 40.56% from previous year.
  • The United Laboratories International Holdings Limited reported a quarterly net income of 1.28 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
  • The United Laboratories International Holdings Limited reported a quarterly net income of 1.41 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of The United Laboratories International Holdings Limited (2023 - 2006)

Historical Annual Net Income of The United Laboratories International Holdings Limited (2023 - 2006)

Year Net Income Net Income Growth
2023 2.7 Billion CNY 70.85%
2022 1.58 Billion CNY 60.01%
2021 988.09 Million CNY 40.56%
2020 702.98 Million CNY 9.54%
2019 641.76 Million CNY -6.03%
2018 682.92 Million CNY 735.3%
2017 81.75 Million CNY 130.02%
2016 -272.36 Million CNY -394.73%
2015 92.41 Million CNY -83.03%
2014 544.61 Million CNY 1350.9%
2013 37.53 Million CNY -71.22%
2012 130.42 Million CNY 54.55%
2011 84.39 Million CNY -89.83%
2010 830.2 Million CNY 74.15%
2009 476.71 Million CNY 25.86%
2008 378.76 Million CNY -20.79%
2007 478.19 Million CNY 174.34%
2006 174.3 Million CNY 0.0%

Peer Net Income Comparison of The United Laboratories International Holdings Limited

Name Net Income Net Income Difference
Pak Fah Yeow International Limited 105.03 Million HKD -2471.759%
Grand Pharmaceutical Group Limited 1.87 Billion HKD -43.689%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 1757.789%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 17691.495%
Qianhai Health Holdings Limited -52.7 Million HKD 5225.415%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -16077.686%
Essex Bio-Technology Limited 275.25 Million HKD -881.383%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 9465.704%
PuraPharm Corporation Limited -106.08 Million HKD 2646.497%
SSY Group Limited 1.31 Billion HKD -104.863%
JBM (Healthcare) Limited 130.46 Million HKD -1970.587%
Jacobson Pharma Corporation Limited 266.96 Million HKD -911.863%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 29.912%